febrile morbidity between use and disuse intraoperative topical absorbable hemostatic agents in patient underwent abdominal hysterectomy febrile morbidity, intraoperative topical absorbable hemostatic agents, abdominal hysterectomy
Conditions
Interventions
usese intraoperative topical absorbable hemostatic agents in patient underwent abdominal hysterectomy,disusese intraoperative topical absorbable hemostatic agents in patient underwent abdominal hyster
Prevention,Prevention
usese intraoperative topical absorbable hemostatic agents,disuse intraoperative topical absorbable hemostatic agents
Sponsors
khonkaen university
Eligibility
Sex/Gender
Female
Age
1 Years to 90 Years
Inclusion criteria
Inclusion criteria: All woman who underwent abdominal hysterectomy
Exclusion criteria
Exclusion criteria: Patients were underlying including chronic inflammation disease, coagulopathy, SLE, HIV, chronic hepatitis and connective tissue disease Patients were diagnosed prior or during intraoperative infection such as intraabdominal abscess Patients were used others intraoperative topical absorbable hemostatic agents excepts Surgicel Fibrillar Patients were not be received appropriate prophylaxis antibiotics Patient documents were not completely registered information
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| febrile morbidity at early 24 hours after end of the intervention hospital database | — |
Secondary
| Measure | Time frame |
|---|---|
| reoperation, vaginal cuff cellulitis and vaginal cuff dehiscence at 30 days after end of the intervention hospital database | — |
Countries
Thailand
Contacts
Public Contactnititorn khantawichai
khonkaen university
Outcome results
None listed